These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 34638820)

  • 1. Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.
    Bárta F; Dedíková A; Bebová M; Dušková Š; Mráz J; Schmeiser HH; Arlt VM; Hodek P; Stiborová M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of activation of aristolochic acid I and II with NADPH:quinone oxidoreductase, sulphotransferases and N-acetyltranferases.
    Martinek V; Kubickova B; Arlt VM; Frei E; Schmeiser HH; Hudecek J; Stiborova M
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():57-70. PubMed ID: 22167209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone.
    Arlt VM; Meinl W; Florian S; Nagy E; Barta F; Thomann M; Mrizova I; Krais AM; Liu M; Richards M; Mirza A; Kopka K; Phillips DH; Glatt H; Stiborova M; Schmeiser HH
    Arch Toxicol; 2017 Apr; 91(4):1957-1975. PubMed ID: 27557898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.
    Stiborova M; Frei E; Arlt VM; Schmeiser HH
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):5-11. PubMed ID: 19365519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.
    Bieler CA; Stiborova M; Wiessler M; Cosyns JP; van Ypersele de Strihou C; Schmeiser HH
    Carcinogenesis; 1997 May; 18(5):1063-7. PubMed ID: 9163697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.
    Stiborová M; Fernando RC; Schmeiser HH; Frei E; Pfau W; Wiessler M
    Carcinogenesis; 1994 Jun; 15(6):1187-92. PubMed ID: 8020154
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Dedı Ková A; Bárta F; Martínek V; Kotalík K; Dušková Š; Mráz J; Arlt VM; Stiborová M; Hodek P
    Chem Res Toxicol; 2020 Nov; 33(11):2804-2818. PubMed ID: 32894017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models.
    Bastek H; Zubel T; Stemmer K; Mangerich A; Beneke S; Dietrich DR
    Toxicology; 2019 May; 420():29-38. PubMed ID: 30940547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cytochromes P450 in metabolism of carcinogenic aristolochic acid I: evidence of their contribution to aristolochic acid I detoxication and activation in rat liver.
    Stiborova M; Mares J; Levova K; Pavlickova J; Barta F; Hodek P; Frei E; Schmeiser HH
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():121-30. PubMed ID: 22167220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats.
    Stiborová M; Bárta F; Levová K; Hodek P; Frei E; Arlt VM; Schmeiser HH
    Arch Toxicol; 2015 Nov; 89(11):2141-58. PubMed ID: 25209566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo.
    Dračínská H; Bárta F; Levová K; Hudecová A; Moserová M; Schmeiser HH; Kopka K; Frei E; Arlt VM; Stiborová M
    Toxicology; 2016 Feb; 344-346():7-18. PubMed ID: 26845733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases.
    Schmeiser HH; Frei E; Wiessler M; Stiborova M
    Carcinogenesis; 1997 May; 18(5):1055-62. PubMed ID: 9163696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.
    Arlt VM; Stiborova M; Schmeiser HH
    Mutagenesis; 2002 Jul; 17(4):265-77. PubMed ID: 12110620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of dicoumarol on the bioactivation of the carcinogen aristolochic acid I in rats.
    Stiborová M; Levová K; Bárta F; Šulc M; Frei E; Arlt VM; Schmeiser HH
    Mutagenesis; 2014 May; 29(3):189-200. PubMed ID: 24598128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney.
    Xing G; Qi X; Chen M; Wu Y; Yao J; Gong L; Nohmi T; Luan Y; Ren J
    Mutat Res; 2012 Mar; 743(1-2):52-8. PubMed ID: 22245565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene.
    Arlt VM; Wiessler M; Schmeiser HH
    Carcinogenesis; 2000 Feb; 21(2):235-42. PubMed ID: 10657963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translesional synthesis on DNA templates containing site-specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid.
    Broschard TH; Wiessler M; von der Lieth CW; Schmeiser HH
    Carcinogenesis; 1994 Oct; 15(10):2331-40. PubMed ID: 7955074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of aristolochic acid I on expression of NAD(P)H:quinone oxidoreductase in mice and rats--a comparative study.
    Bárta F; Levová K; Frei E; Schmeiser HH; Arlt VM; Stiborová M
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Jul; 768():1-7. PubMed ID: 24769487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Hájek M; Frei E; Schmeiser HH
    Gen Physiol Biophys; 2001 Dec; 20(4):375-92. PubMed ID: 11989648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of site-specifically located aristolochic acid DNA adducts on in vitro DNA synthesis by human DNA polymerase alpha.
    Broschard TH; Wiessler M; Schmeiser HH
    Cancer Lett; 1995 Nov; 98(1):47-56. PubMed ID: 8529205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.